Abn Amro Investment Solutions Abcam PLC Transaction History

Abn Amro Investment Solutions

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Sep 05, 2025	SELL	$0.0 - $23.99 $0 - $6.47 Million	-269,884 Closed	0 $0
Q3 2023 Nov 07, 2025	BUY	$21.54 - $24.41 $5.81 Million - $6.59 Million	269,884 New	269,884 $6.11 Billion
Q3 2023 Sep 05, 2025	SELL	$21.54 - $24.41 $12.9 Million - $14.7 Million	-600,761 Reduced 69.0%	269,884 $6.11 Billion
Q2 2023 Sep 05, 2025	SELL	$12.62 - $24.47 $1.03 Million - $2 Million	-81,815 Reduced 8.59%	870,645 $21.3 Billion
Q1 2023 Sep 05, 2025	BUY	$12.98 - $17.1 $12.4 Million - $16.3 Million	952,460 New	952,460 $12.8 Billion

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

Stay updated on Abn Amro Investment Solutions with notifications on news.